Franklin Resources Inc Genmab A/S Transaction History

Franklin Resources Inc

$346 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Genmab A/S stock. As of the latest transaction made, Franklin Resources Inc holds 25,663 shares of GMAB stock, worth $528,401. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,663

Previous 27,067 5.19%

Holding current value

$528,401

Previous $680,000 8.09%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$23.84 - $28.48 $33,471 - $39,985	-1,404 Reduced 5.19%	25,663 $625,000
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $90,040 - $108,457	-3,583 Reduced 11.69%	27,067 $680,000
Q1 2024 May 13, 2024	BUY	$26.43 - $32.77 $7,902 - $9,798	299 Added 0.99%	30,650 $916,000
Q4 2023 Feb 09, 2024	SELL	$27.94 - $35.44 $14.7 Million - $18.7 Million	-527,256 Reduced 94.56%	30,351 $966,000
Q3 2023 Nov 13, 2023	SELL	$35.27 - $42.24 $3.1 Million - $3.72 Million	-88,030 Reduced 13.63%	557,607 $19.7 Million
Q2 2023 Aug 11, 2023	BUY	$37.4 - $42.94 $4.17 Million - $4.79 Million	111,451 Added 20.86%	645,637 $24.5 Million
Q1 2023 May 12, 2023	BUY	$34.88 - $43.22 $3.24 Million - $4.01 Million	92,824 Added 21.03%	534,186 $20.2 Million
Q4 2022 Feb 10, 2023	BUY	$33.8 - $47.06 $14.6 Million - $20.3 Million	431,763 Added 4498.0%	441,362 $18.7 Million
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $5,484 - $65,008	-174 Reduced 1.78%	9,599 $309,000
Q2 2022 Aug 11, 2022	BUY	$26.83 - $38.57 $89,665 - $128,900	3,342 Added 51.97%	9,773 $318,000
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $12,999 - $16,665	-420 Reduced 6.13%	6,431 $233,000
Q4 2021 Feb 11, 2022	BUY	$35.87 - $47.12 $32,821 - $43,114	915 Added 15.41%	6,851 $271,000
Q3 2021 Nov 12, 2021	BUY	$41.55 - $48.72 $16,246 - $19,049	391 Added 7.05%	5,936 $259,000
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $182,319 - $247,140	5,545 New	5,545 $226,000
Q1 2021 May 13, 2021	SELL	$30.92 - $44.4 $158,032 - $226,928	-5,111 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$33.66 - $40.76 $172,036 - $208,324	5,111 New	5,111 $208,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Genmab A/S Transaction History